Poractant Alfa

Form: Intratracheal suspension

Strength: 80 mg/mL

Reference Brands: Curosurf(Eu & US)

Category: Respiratory Disorder

Poractant Alfa, sold under the brand name Curosurf, is a natural surfactant used to treat Respiratory Distress Syndrome (RDS) in premature infants. Derived from porcine lung extract, it contains vital surfactant proteins (SP-B and SP-C) that help reduce surface tension in the lungs and improve oxygenation. Curosurf is administered via intratracheal suspension and is available in 80 mg/mL concentrations in 1.5 mL (120 mg) and 3 mL (240 mg) vials. Widely approved and marketed in both the US and EU, Curosurf is trusted in NICUs globally for its proven efficacy in neonatal respiratory support.